Overexpression of Her-2 upregulates FoxM1 in gastric cancer

Author：

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.33, Iss.6, 2014-01, pp. : 1531-1538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer

Oncology Research and Treatment, Vol. 40, Iss. 4, 2017-03 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer

International Journal of Molecular Medicine, Vol. 33, Iss. 6, 2014-01 ,pp. : 1514-1522

Spandidos Publications

Access to resources Recommend Favorite

Targeted HER2 Treatment in Advanced Gastric Cancer

Oncology, Vol. 78, Iss. 1, 2010-02 ,pp. : 26-33

Karger

Access to resources Recommend Favorite

The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-07 ,pp. : 644-648

Karger

Access to resources Recommend Favorite

Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 147-156

Karger

Access to resources Recommend Favorite